Latest news
Soligenix culls topical lymphoma asset after Phase III miss - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 11:17:14 GMTForm 424B3 SOLIGENIX, INC. - StreetInsiderStreetInsider · Fri, 07 Aug 2026 20:09:05 GMTSoligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 20:06:00 GMTSoligenix Q2 Results: EPS beats estimates by 20% - scanx.tradescanx.trade · Fri, 07 Aug 2026 18:00:42 GMTSoligenix Releases Q2 2026 Financial Results - AlphaStreetAlphaStreet · Fri, 07 Aug 2026 16:18:10 GMTSoligenix Announces Recent Updates and Second Quarter 2026 Financial Results - PR NewswirePR Newswire · Fri, 07 Aug 2026 11:30:00 GMTSNGX Stock More Than Doubles In Pre-Market, Eyes $1 Breakout For First Time In A Month On Ebola Vaccine Optimism - StocktwitsStocktwits · Wed, 05 Aug 2026 08:33:51 GMTSOLIGENIX, INC. SEC Filing (Aug 3, 2026) - Stock TitanStock Titan · Mon, 03 Aug 2026 20:24:11 GMT